Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1
Open Access
- 1 March 2009
- journal article
- review article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (12) , 7425-7429
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- SUMOylation of the Polyglutamine Repeat Protein, Ataxin-1, Is Dependent on a Functional Nuclear Localization SignalJournal of Biological Chemistry, 2005
- Ataxin-1 Nuclear Localization and AggregationCell, 1998
- The anatomy of the cerebellumTrends in Neurosciences, 1998
- Mice Lacking Ataxin-1 Display Learning Deficits and Decreased Hippocampal Paired-Pulse FacilitationJournal of Neuroscience, 1998
- staggerer phenotype in retinoid-related orphan receptor α-deficient miceProceedings of the National Academy of Sciences, 1998
- Orphan nuclear receptor RORα-deficient mice display the cerebellar defects of staggererMechanisms of Development, 1998
- Disruption of the nuclear hormone receptor RORα in staggerer miceNature, 1996
- Expression analysis of the ataxin–1 protein in tissues from normal and spinocerebellar ataxia type 1 individualsNature Genetics, 1995
- Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type INature Genetics, 1993